ApiRegenin, an Animal-Derived Platelet-Rich Plasma Extract, Accelerates Wound Healing of Chronic Diabetic Ulcer in Mice
Pharmaceutics · 14.07.2026 · 18 (7) · 856
DOI: 10.3390/pharmaceutics18070856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 14.07.2026. Verfasst von Zheng-Qi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 999077…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Technology Commission, Chinese Medicine Development Fund, Shenzhen Science and Technology Innovation Commission.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Platelet-rich plasma (PRP) plays a crucial role in chronic wound healing by releasing growth factors that regulate inflammation, promote angiogenesis, and stimulate tissue regeneration. Methods and Results: Here, an animal source of PRP, named ApiRegenin and derived from cultivated deer blood, was established. Specific protein and non-protein biomarkers—including nicotinamide, palmitic acid, IGF, and fibronectin—were validated to ensure batch-to-batch quality control. The pharmacological properties of ApiRegenin in cultured cells transfected with DNA encoding HRE and NF-κB reporter constructs were validated, serving as a functional control. In a skin-defective model of db/db diabetic mice, accelerated wound healing was observed following ApiRegenin treatment. Histological analysis revealed enhancements of re-epithelialization, granulation tissue formation, and collagen deposition. In parallel, the immunofluorescence staining of CD31, α-SMA, and VEGF was upregulated, indicating the promotion of angiogenesis. Furthermore, ApiRegenin treatment shifted the local immune microenvironment toward an M2-like macrophage phenotype, characterized by the downregulation of iNOS and the contrastive upregulation of Arg-1. At the molecular level, transcriptomic enrichment analysis suggested the prominent involvement of the HIF-1, PI3K-Akt, and TNF signaling pathways.
Conclusions
These findings demonstrate that ApiRegenin effectively accelerates diabetic wound healing by promoting angiogenesis and modulating macrophage polarization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 999077, China.
- Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Shenzhen 518057, China.
ORCID-Profile: Minnie Wing-Yi Mak, Xiong Gao, Karl Wah-Keung Tsim
Förderung
- Innovation and Technology Commission
- Chinese Medicine Development Fund
- Shenzhen Science and Technology Innovation Commission
- Hong Kong Innovation and Technology Commission
Zitieren
APA
Wang, Z. Q., Mak, M. W., Gao, X., Ye, Y. T., Yik, C. L., Dong, T. T., & Tsim, K. W. (2026). ApiRegenin, an Animal-Derived Platelet-Rich Plasma Extract, Accelerates Wound Healing of Chronic Diabetic Ulcer in Mice. Pharmaceutics, 18(7), 856. https://doi.org/10.3390/pharmaceutics18070856
Vancouver
Wang ZQ, Mak MW, Gao X, Ye YT, Yik CL, Dong TT, et al. ApiRegenin, an Animal-Derived Platelet-Rich Plasma Extract, Accelerates Wound Healing of Chronic Diabetic Ulcer in Mice. Pharmaceutics. 2026;18(7):856. doi:10.3390/pharmaceutics18070856
BibTeX
@article{Wang2026,
author = {Wang, Zheng-Qi and Mak, Minnie Wing-Yi and Gao, Xiong and Ye, Yu-Tong and Yik, Christina Lok-Pan and Dong, Tina Ting-Xia and Tsim, Karl Wah-Keung},
title = {ApiRegenin, an Animal-Derived Platelet-Rich Plasma Extract, Accelerates Wound Healing of Chronic Diabetic Ulcer in Mice},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {856},
doi = {10.3390/pharmaceutics18070856}
}
EUVIMED